Skip to main content
SpringerLink
Log in

Cytopathology of Asbestos-Associated Diseases

  • Chapter
Pathology of Asbestos-Associated Diseases

Summary and Conclusions

The evaluation of patients with respiratory disease suspected or alleged to complicate exposure to asbestos requires the synthesis of clinical, radiographic, and laboratory data, as well as data gleaned from the inspection of pathologic specimens. The examination of cytologic materials including body cavity fluids, bronchial washings, and sputa (often obtained with a minimum of expense and attendant morbidity) may provide a wealth of information regarding the various disease states believed to be related to prior asbestos exposure. Moreover, these specimens may lend themselves to the application of special techniques discussed elsewhere in this book to identify and quantify asbestos fibers and thereby implicate them in the causation of disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 259.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Greenberg SD, Hurst GA, Matlage WT, Miller JM, Hurst IJ, Mabry LC: Tyler asbestos workers program. Ann NY Acad Sci 271:353–364, 1976.

    CAS  PubMed  Google Scholar 

  2. Roggli VL, Greenberg SD, Seitzman LH, McGavran MH, Hurst GA, Spivey CG, Nelson KG, Hieger LR: Pulmonary fibrosis, carcinoma and asbestos body counts in amosite asbestos workers. Am J Clin Pathol 73:496–503, 1980.

    CAS  PubMed  Google Scholar 

  3. Stewart MJ, Haddow AC: Demonstration of the peculiar bodies of pulmonary asbestosis in material obtained by lung puncture and in the sputum. J Pathol Bacteriol 32:172, 1929.

    Article  CAS  Google Scholar 

  4. An SH, Koprowska I: Primary cytologic diagnosis of asbestosis associated with bronchogenic carcinoma: Case report and review of the literature. Acta Cytol 6:391–398, 1962.

    CAS  PubMed  Google Scholar 

  5. Huuskonen MS, Taskinen E, Vaaranen V: Sputum cytology of asbestosis patients. Scand J Work Environ Health 4:284–294, 1978.

    CAS  PubMed  Google Scholar 

  6. Gupta PK, Frost JK: Cytologic changes associated with asbestos exposure. Sem Oncol 8:283–289, 1981.

    CAS  Google Scholar 

  7. Kotin P, Paul W: Results of a lung cancer detection program in an asbestos industry. Recent Results in Cancer Research 82:131–137, 1982.

    CAS  PubMed  Google Scholar 

  8. Dodson RF, Williams MG, McLarty JW, Hurst GA: Asbestos bodies and particulate matter in sputum from former asbestos workers: An ultrastructural study. Acta Cytol 27:635–40, 1983.

    CAS  PubMed  Google Scholar 

  9. Kobusch AB, Simard A, Feldstein M, Vauclair R, Gibbs GW, Bergeron F, Morissette N, Davis R: Pulmonary cytology in chrysotile asbestos workers. J Chron Dis 37:599–607, 1984.

    Article  CAS  PubMed  Google Scholar 

  10. DeMay RM: Respiratory Cytology. Ch. 7 In: The Art and Science of Cytopathology: Exfoliative Cytology, Chicago: ASCPPress, 1996, pp. 207–256.

    Google Scholar 

  11. Bocking A, Biesterfeld S, Chatelain R: Diagnosis of bronchial carcinoma on sections of paraffin-embedded sputum: Sensitivity and specificity of an alternative to routine cytology. Acta Cytol 36:37–42, 1992.

    CAS  PubMed  Google Scholar 

  12. Nakajima J, Manabe T, Yagi S: Appearance of mesothelioma cells in sputum: A case report. Acta Cytol 36:731–736, 1999.

    Google Scholar 

  13. Naryshkin S, Young NA: Respiratory cytology: A review of non-neoplastic mimics of malignancy. Diag Cytopathol 9:89–97, 1993.

    CAS  Google Scholar 

  14. Colby TV, Koss MN, Travis WT: Tumors of the Lower Respiratory Tract. Atlas of Tumor Pathology, Series 3, Fascicle 13, Washington, DC: Armed Forces Institute of Pathology, 1995, pp. 259–278.

    Google Scholar 

  15. Epler GR, McLoud TC, Gaensler EA: Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA 247:617–622, 1982.

    Article  CAS  PubMed  Google Scholar 

  16. Chahinian AP, Pajak TF, Holand JF: Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med 96:746–775, 1982.

    CAS  PubMed  Google Scholar 

  17. Whitaker D, Shilkin KB, Sterrett GF: Cytologic appearance of malignant mesothelioma, In: Malignant Mesothelioma (Henderson DW, Shilkin KB, Langlois SLP, eds.) New York: Hemisphere, 1991, pp. 167–182.

    Google Scholar 

  18. Leong ASY, Stevens MW, Mukherjee TM: Malignant mesothelioma: cytologic diagnosis with histologic, immunohistochemical and ultrastructural correlation. Sem Diag Pathol 9:141–150, 1992.

    CAS  Google Scholar 

  19. Stevens MW: Cytopathology of malignant mesothelioma: A stepwise logistic regression analysis. Diag Cytopathol 8:333–344, 1992.

    CAS  Google Scholar 

  20. Zakowski MF, Ianuale-Sherman A: Cytology of pericardial effusions in AIDS patients. Diag Cytopathol 9:266–269, 1993.

    CAS  Google Scholar 

  21. McCaughey WTE, Kannerstein M, Churg J: Tumors and pseudotumors of the serous membranes. In: Atlas of Tumor Pathology, Series 2, Fascicle 20, Washington, DC: Armed Forces Institute of Pathology, 1985, pp. 60–61.

    Google Scholar 

  22. Attanoos RL, Gibbs AR: Pathology of malignant mesothelioma. Histopathol 30:403–418, 1997.

    Article  CAS  Google Scholar 

  23. Tickman RJ, Cohen CC, Varma VA, Fekete PS, Derose PB: Distinction between carcinoma cells and mesothelial cells in serous effusions—usefulness of immunohistochemistry. Acta Cytol 34:491–496, 1990.

    CAS  PubMed  Google Scholar 

  24. Fetsch PA, Simsir A, Abati A: Comparison of antibodies to HBME-1 and calretinin for the detection of mesothelial cells in effusion cytology. Diag Cytopathol 25:158–161, 2001.

    Article  CAS  Google Scholar 

  25. Lozano MD, Panizo A, Toledo GR, Sola JJ, Pardo-Mindan J: Immunocyto-chemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears. Cancer 93:68–72, 2001.

    Article  CAS  PubMed  Google Scholar 

  26. Barberis MC, Faleri M, Veronese S, Casadio C, Viale G: Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions. Diag Cytopathol 41:1757–1761, 1997.

    CAS  Google Scholar 

  27. Hecht JL, Pinkus JL, Weinstein LJ, Pinkus GS: The value of thyroid transcription factor 1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Am J Clin Pathol 116:483–488, 2001.

    Article  CAS  PubMed  Google Scholar 

  28. Motherby H, Kube M, Friedrichs N, Jadjari B, et al.: Immunocytochemistry and DNA-image cytometry in diagnostic effusion cytology. Part 1. Analyt Cell Pathol 19:7–20, 1999.

    CAS  Google Scholar 

  29. Wieczorek TJ, Krane JF: Diagnostic utility of calretinin immunohistochemistry in cytologic cell block preparations. Cancer 90:312–319, 2000.

    Article  CAS  PubMed  Google Scholar 

  30. Kitazume H, Kitamura K, Mukai K, Inayama Y, Kawano N, Nakamura N, Sano J, Mitsui K, Yoshida S, Nakatani Y: Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma and adenocarcinoma: utility of combined E-cadherin and calretinin immunostaining. Cancer 90:55–60, 2000.

    Article  CAS  PubMed  Google Scholar 

  31. Davidson B, Nielsen S, Christensen J, Asschenfeldt P, Berner A, Risberg R, Johansen P: The role of desmin and N-cadherin in effusion cytology: A comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol 25:1405–1412, 2001.

    Article  CAS  PubMed  Google Scholar 

  32. Simsir A, Fetsch P, Mehta D, Zakowski M, Abati A: E-cadherin, N-cadherin and calretinin in pleural effusions: the good, the bad, the worthless. Diag Cytopathol 20:125–130, 1999.

    Article  CAS  Google Scholar 

  33. Lee A, Baloch ZW, Yu G, Gupta PK: Mesothelial hyperplasia with reactive atypia: diagnostic pitfalls and role of immunohistochemical studies—a case report. Diag Cytopathol 22:113–116, 2000.

    Article  CAS  Google Scholar 

  34. Sakuma N, Toshiaki K, Ishihara T: Ultrastructure of pleural mesothelioma and pulmonary adenocarcinoma in malignant effusions as compared with reactive mesothelial cells. Acta Cytol 43:777–779, 1999.

    CAS  PubMed  Google Scholar 

  35. DiBonito L, Falconieri G, Colautti I, Gori DB, Dudine S, Giarelli L: Cytopathology of malignant mesothelioma: a study of its patterns and histological bases. Diag Cytopathol 9:25–31, 1992.

    Google Scholar 

  36. Sherman ME, Mark EJ: Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma. Arch Pathol Lab Med 114:845–851, 1990.

    CAS  PubMed  Google Scholar 

  37. Johnston WW: Cytologic correlations. Ch. 31 In: Pulmonary Pathology (Dail DH, Hammar SP, eds.) New York: Springer-Verlag, 1988, pp. 1029–1095.

    Google Scholar 

  38. Yu GH, Baloch ZW, Gupta PK: Cytopathology of metastatic mesothelioma in fine needle aspiration specimens. Diag Cytopathol 20:328–332, 1999.

    Article  CAS  Google Scholar 

  39. Nguyen GK, Akin MR, Villanueva RR, Slatnik J: Cytopathlogy of malignant mesothelioma of the pleura in fine needle aspiration biopsy. Diag Cytopathol 21:253–259, 1999.

    Article  CAS  Google Scholar 

  40. Yu GH, Soma L, Hahn S, Friedberg JS: Changing clinical course of patients with malignant mesothelioma: implications for FNA cytology and utility of immunocytochemical staining. Diag Cytopathol 24:322–327, 2001.

    Article  CAS  Google Scholar 

  41. Obers VJ, Leiman G, Girdwood RW, Spiro FI: Primary malignant pleural tumors (mesotheliomas) presenting as localized masses: Fine needle aspiration cytologic findings, clinical and radiologic features and review of the literature. Acta Cytol 32:567–575, 1988.

    CAS  PubMed  Google Scholar 

  42. Sterrett GF, Whitaker D, Shilkin KB, Walters MNI: Fine needle aspiration cytology of malignant mesothelioma. Acta Cytol 31:185–193, 1987.

    CAS  PubMed  Google Scholar 

  43. Friedman MT, Gentile P, Tarectecan A, Fuchs A: Malignant mesothelioma: Immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Arch Pathol Lab Med 120:959–966, 1996.

    CAS  PubMed  Google Scholar 

  44. Granados R, Cibas ES, Fletcher JA: Cytogenetic analysis from effusions malignant mesothelioma—a diagnostic adjunct to cytology. Acta Cytol 38:711–717, 1994.

    CAS  PubMed  Google Scholar 

  45. Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES: The role of cytologic evaluation of pleural fluid in the diagnosis of mesothelioma. Chest 111:106–109, 1997.

    CAS  PubMed  Google Scholar 

  46. Greenberg SD: Asbestos lung disease. Sem Resp Med 4:130–136, 1982.

    Google Scholar 

  47. Mace ML, McLemore TL, Roggli VL, Brinkley BR, Greenberg SD: Scanning electron microscopic examination of human asbestos bodies. Cancer Lett 9:95–104, 1980.

    Article  PubMed  Google Scholar 

  48. McLemore TL, Mace ML, Roggli VL, Marshall MV, Lawrence EC, Wilson RK, Martin RR, Brinkley BR, Greenberg SD: Asbestos body phagocytosis by human free alveolar macrophages. Cancer Lett 9:85–93, 1980.

    Article  CAS  PubMed  Google Scholar 

  49. Dumortier P, Broucke I, De Vuyst P: Pseudoasbestos bodies and fibers in bronchoalveolar lavage of refractory ceramic fiber users. Am J Respir Crit Care Med 164:499–503, 2001.

    CAS  PubMed  Google Scholar 

  50. Roggli VL, Piantadosi CA, Bell DY: Asbestos bodies in bronchoalveolar lavage fluid: A study of 20 asbestos-exposed individuals and comparison to patients with other chronic interstitial lung diseases. Acta Cytol 30: 470–476, 1986.

    CAS  PubMed  Google Scholar 

  51. Modin BE, Greenberg SD, Buffler PA, Lockhart JA, Seitzman LH, Awe RJ: Asbestos bodies in a general hospital/clinic population. Acta Cytol 26: 667–670, 1982.

    CAS  PubMed  Google Scholar 

  52. Farley ML, Greenberg SD, Shuford EH, Hurst GA, Spivey CG: Ferruginous bodies in sputa of former asbestos workers. Acta Cytol 21:693–700, 1977.

    CAS  PubMed  Google Scholar 

  53. Bignon J, Sebastien P, Jaurand MC, Hem B: Microfiltration methods for quantitative study of fibrous particles in biologic specimens. Environ Health Persp 9:155–160, 1974.

    CAS  Google Scholar 

  54. Roggli VL, McLarty JW, Greenberg SD, Hurst GA, Hieger LR, Farley ML, Mabry LC: Comparison of sputum and lung asbestos body counts in former asbestos workers. Am Rev Respir Dis 122:941–945, 1980.

    CAS  PubMed  Google Scholar 

  55. McLarty JW, Greenberg SD, Hurst GA, Spivey CG, Seitzman LH, Hieger LR, Farley ML, Mabry LC: The clinical significance of ferruginous bodies in sputa. J Occup Med 22:92–96, 1980.

    CAS  PubMed  Google Scholar 

  56. Teschler H, Konietzko N, Schoenfeld B, Ramin C, Schraps T, Costabel U: Distribution of asbestos bodies in the human lung as determined by bronchoalveolar lavage. Am Rev Respir Dis 147:1211–1215, 1993.

    CAS  PubMed  Google Scholar 

  57. De Vuyst P, Dumortier P, Moulin E, Yourassowsky N, Yernault JC: Diagnostic value of asbestos bodies in bronchoalveolar lavage fluid. Am Rev Respir Dis 136:1219–1224, 1987.

    PubMed  Google Scholar 

  58. Roggli VL, Coin PG, McIntyre NR, Bell DY: Asbestos content of bronchoalveolar lavage fluid: a comparison of light and scanning electron microscopic analysis. Acta Cytol 38:502–510, 1994.

    CAS  PubMed  Google Scholar 

  59. Karjalainen A, Anttila A, Mantyla T, Taskinen E, Kyyronen P, Tukianen P: Asbestos bodies in bronchoalveolar lavage fluid in relation to occupational history. Am J Ind Med 26:645–654, 1994.

    CAS  PubMed  Google Scholar 

  60. Karjalainen A, Piipari R, Mantyla T, Monkkonen M, Numinen M, Tukianen P, Vanhala E, Anttila S: Asbestos bodies in bronchoalveolar lavage in relation to asbestos bodies and asbestos fibers in lung parenchyma. Eur Respir J 9:1000–1005, 1996.

    Article  CAS  PubMed  Google Scholar 

  61. De Vuyst P, Dumortier P, Moulin E: Asbestos bodies in bronchoalveolar lavage reflects lung asbestos body concentration. Eur Resp J 1:362–367, 1988.

    Google Scholar 

  62. Sebastien P, Armstrong B, Monchaux G, Bignon J: Asbestos bodies in bronchoalveolar lavage fluid and in lung parenchyma. Am Rev Respir Dis 137:75–78, 1988.

    CAS  PubMed  Google Scholar 

  63. Schwartz DA, Galvin JR, Burmeister LF, Merchant RK, Dayton CS, Merchant JA, Hunninghake GW: The clinical utility and reliability of asbestos bodies in bronchoalveolar fluid. Am Rev Respir Dis 144:684–688, 1991.

    CAS  PubMed  Google Scholar 

  64. Albin M, Johansson L, Pooley FD, Jakobsson K, Attewell R, Mitra R: Mineral fibres, fibrosis and asbestos bodies in lung tissue. Br J Ind Med 47:767–774, 1990.

    CAS  PubMed  Google Scholar 

  65. Teschler H, Hoheisel G, Fischer M, Muller KM, Konietzko N, Costabel U: The content of asbestos bodies in the bronchoalveolar fluid as a parameter of an increased pulmonary asbestos load. Deutsch Med Wochenschr 118:1749–1754, 1993.

    Article  CAS  Google Scholar 

  66. Teschler H, Friedrichs KH, Hoheisel GB, Wick G, Soltner U, Thompson AB, Konietzko N, Costabel U: Asbestos fibers in bronchoalveolar lavage and lung tissue of former asbestos workers. Am J Respir Crit Care Med 149:641–645, 1994.

    CAS  PubMed  Google Scholar 

  67. Dumortier P, Coplu L, de Martier V, Emri S, Baris I, De Vuyst P: Assessment of environmental asbestos exposure in Turkey by bronchoalveolar lavage. Am J Respir Crit Care Med 158:1815–1824, 1998.

    CAS  PubMed  Google Scholar 

  68. De Vuyst P, Dumortier P, Gevenois PA: Analysis of asbestos bodies in BAL from subjects with particulate exposures. Am J Ind Med 31:699–704, 1997.

    Article  PubMed  Google Scholar 

  69. Roggli VL, Johnston WW, Kaminsky DB: Asbestos bodies in fine needle aspirates of the lung. Acta Cytol 28:494–498, 1984.

    Google Scholar 

  70. Leiman G: Asbestos bodies in fine needle aspirates of lung masses. Acta Cytol 35:171–174, 1991.

    CAS  PubMed  Google Scholar 

Download references

Authors
  1. Thomas A. Sporn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kelly J. Butnor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Victor L. Roggli
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Duke University, Durham, North Carolina, 27710, USA

    Victor L. Roggli MD (Professor of Pathology) (Professor of Pathology)

  2. Durham VA Medical Centers, Durham, North Carolina, 27710, USA

    Victor L. Roggli MD (Professor of Pathology) (Professor of Pathology)

  3. Department of Pathology, Duke University Medical Center, Durham, NC, 27710, USA

    Thomas A. Sporn MD (Assistant Professor) (Assistant Professor)

  4. University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, USA

    Tim D. Oury MD, PhD (Assistant Professor of Pathology) (Assistant Professor of Pathology)

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Sporn, T.A., Butnor, K.J., Roggli, V.L. (2004). Cytopathology of Asbestos-Associated Diseases. In: Roggli, V.L., Sporn, T.A., Oury, T.D. (eds) Pathology of Asbestos-Associated Diseases. Springer, New York, NY. https://doi.org/10.1007/0-387-21819-X_9

Download citation

  • DOI: https://doi.org/10.1007/0-387-21819-X_9

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-20090-3

  • Online ISBN: 978-0-387-21819-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation